Cargando…

Residual Bone Marrow T & NK-Cells at Diagnosis in Pediatric Pre-B-ALL: A Case–Control Study

BACKGROUND: Mature bone marrow T lymphocytes and NK may have a special relevance in the control of the malignant growth. OBJECTIVE: We aimed to assess the percentage of the residual BM T-cells, (T-helper –T-cytotoxic- NKT) and the NK cells of childhood precursor B-lymphoblastic leukemia (B-ALL) as a...

Descripción completa

Detalles Bibliográficos
Autores principales: Eldewi, Dalia Mahmoud, El‑Hagrasy, Hanan A, Gouda, Rasha Mahmoud, Hassan, Mohammed Abd El Malik, Kamel, Shimaa Moustafa, Abd El Haliem, Naglaa F, Anani, Haneya A A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369084/
https://www.ncbi.nlm.nih.gov/pubmed/35966509
http://dx.doi.org/10.2147/IJGM.S375991
_version_ 1784766349970505728
author Eldewi, Dalia Mahmoud
El‑Hagrasy, Hanan A
Gouda, Rasha Mahmoud
Hassan, Mohammed Abd El Malik
Kamel, Shimaa Moustafa
Abd El Haliem, Naglaa F
Anani, Haneya A A
author_facet Eldewi, Dalia Mahmoud
El‑Hagrasy, Hanan A
Gouda, Rasha Mahmoud
Hassan, Mohammed Abd El Malik
Kamel, Shimaa Moustafa
Abd El Haliem, Naglaa F
Anani, Haneya A A
author_sort Eldewi, Dalia Mahmoud
collection PubMed
description BACKGROUND: Mature bone marrow T lymphocytes and NK may have a special relevance in the control of the malignant growth. OBJECTIVE: We aimed to assess the percentage of the residual BM T-cells, (T-helper –T-cytotoxic- NKT) and the NK cells of childhood precursor B-lymphoblastic leukemia (B-ALL) as an indicator of innate and adaptive immunity in these patients. SUBJECTS AND METHODS: This study was conducted on 40 B-ALL patients, and 40 apparently healthy matched children served as a control group. The flow cytometry was used to assess the percentage of the residual BM T-cells (T-helper, T-cytotoxic and NKT), and the NK cells. RESULTS: Compared with the control group, the percentage of the residual BM T-cells, its subtypes (T-helper, T-cytotoxic), and NKT cells in addition to the NK cells was significantly decreased in Group IA, and Group IB, but there was no significant difference between Group IA and Group IB in all studied parameters. In terms of the CD4/CD8 ratio, there was a significant increase in Group IA as compared to the control group (P < 0.026), but there were no significant statistical differences in CD4/CD8 ratio between Groups IB, and the control. Likewise, in CD4/CD8 ratio between groups IA, and Groups IB (P > 0.05). The percentage of NK, and NKT cells shows a significant increase in Hepatomegaly and Splenomegaly, as compared to non-Hepatomegaly and non-Splenomegaly patients of Groups IB (P < 0.05). However, there was a significant increase in statistical differences in the percentage of NKT cell between non-Splenomegaly, as compared to Splenomegaly patients of Group IA (P < 0.05). Additionally, there is a negative correlation between B.M Blast% to CD4/CD8 ratio and NK%, but there is no significant correlation between B.M Blast% to NK T% in the group 1 A.
format Online
Article
Text
id pubmed-9369084
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-93690842022-08-12 Residual Bone Marrow T & NK-Cells at Diagnosis in Pediatric Pre-B-ALL: A Case–Control Study Eldewi, Dalia Mahmoud El‑Hagrasy, Hanan A Gouda, Rasha Mahmoud Hassan, Mohammed Abd El Malik Kamel, Shimaa Moustafa Abd El Haliem, Naglaa F Anani, Haneya A A Int J Gen Med Original Research BACKGROUND: Mature bone marrow T lymphocytes and NK may have a special relevance in the control of the malignant growth. OBJECTIVE: We aimed to assess the percentage of the residual BM T-cells, (T-helper –T-cytotoxic- NKT) and the NK cells of childhood precursor B-lymphoblastic leukemia (B-ALL) as an indicator of innate and adaptive immunity in these patients. SUBJECTS AND METHODS: This study was conducted on 40 B-ALL patients, and 40 apparently healthy matched children served as a control group. The flow cytometry was used to assess the percentage of the residual BM T-cells (T-helper, T-cytotoxic and NKT), and the NK cells. RESULTS: Compared with the control group, the percentage of the residual BM T-cells, its subtypes (T-helper, T-cytotoxic), and NKT cells in addition to the NK cells was significantly decreased in Group IA, and Group IB, but there was no significant difference between Group IA and Group IB in all studied parameters. In terms of the CD4/CD8 ratio, there was a significant increase in Group IA as compared to the control group (P < 0.026), but there were no significant statistical differences in CD4/CD8 ratio between Groups IB, and the control. Likewise, in CD4/CD8 ratio between groups IA, and Groups IB (P > 0.05). The percentage of NK, and NKT cells shows a significant increase in Hepatomegaly and Splenomegaly, as compared to non-Hepatomegaly and non-Splenomegaly patients of Groups IB (P < 0.05). However, there was a significant increase in statistical differences in the percentage of NKT cell between non-Splenomegaly, as compared to Splenomegaly patients of Group IA (P < 0.05). Additionally, there is a negative correlation between B.M Blast% to CD4/CD8 ratio and NK%, but there is no significant correlation between B.M Blast% to NK T% in the group 1 A. Dove 2022-08-07 /pmc/articles/PMC9369084/ /pubmed/35966509 http://dx.doi.org/10.2147/IJGM.S375991 Text en © 2022 Eldewi et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Eldewi, Dalia Mahmoud
El‑Hagrasy, Hanan A
Gouda, Rasha Mahmoud
Hassan, Mohammed Abd El Malik
Kamel, Shimaa Moustafa
Abd El Haliem, Naglaa F
Anani, Haneya A A
Residual Bone Marrow T & NK-Cells at Diagnosis in Pediatric Pre-B-ALL: A Case–Control Study
title Residual Bone Marrow T & NK-Cells at Diagnosis in Pediatric Pre-B-ALL: A Case–Control Study
title_full Residual Bone Marrow T & NK-Cells at Diagnosis in Pediatric Pre-B-ALL: A Case–Control Study
title_fullStr Residual Bone Marrow T & NK-Cells at Diagnosis in Pediatric Pre-B-ALL: A Case–Control Study
title_full_unstemmed Residual Bone Marrow T & NK-Cells at Diagnosis in Pediatric Pre-B-ALL: A Case–Control Study
title_short Residual Bone Marrow T & NK-Cells at Diagnosis in Pediatric Pre-B-ALL: A Case–Control Study
title_sort residual bone marrow t & nk-cells at diagnosis in pediatric pre-b-all: a case–control study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369084/
https://www.ncbi.nlm.nih.gov/pubmed/35966509
http://dx.doi.org/10.2147/IJGM.S375991
work_keys_str_mv AT eldewidaliamahmoud residualbonemarrowtnkcellsatdiagnosisinpediatricpreballacasecontrolstudy
AT elhagrasyhanana residualbonemarrowtnkcellsatdiagnosisinpediatricpreballacasecontrolstudy
AT goudarashamahmoud residualbonemarrowtnkcellsatdiagnosisinpediatricpreballacasecontrolstudy
AT hassanmohammedabdelmalik residualbonemarrowtnkcellsatdiagnosisinpediatricpreballacasecontrolstudy
AT kamelshimaamoustafa residualbonemarrowtnkcellsatdiagnosisinpediatricpreballacasecontrolstudy
AT abdelhaliemnaglaaf residualbonemarrowtnkcellsatdiagnosisinpediatricpreballacasecontrolstudy
AT ananihaneyaaa residualbonemarrowtnkcellsatdiagnosisinpediatricpreballacasecontrolstudy